It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Understanding genetic architecture of plasma lipidome could provide better insights into lipid metabolism and its link to cardiovascular diseases (CVDs). Here, we perform genome-wide association analyses of 141 lipid species (n = 2,181 individuals), followed by phenome-wide scans with 25 CVD related phenotypes (n = 511,700 individuals). We identify 35 lipid-species-associated loci (P <5 ×10−8), 10 of which associate with CVD risk including five new loci-COL5A1, GLTPD2, SPTLC3, MBOAT7 and GALNT16 (false discovery rate<0.05). We identify loci for lipid species that are shown to predict CVD e.g., SPTLC3 for CER(d18:1/24:1). We show that lipoprotein lipase (LPL) may more efficiently hydrolyze medium length triacylglycerides (TAGs) than others. Polyunsaturated lipids have highest heritability and genetic correlations, suggesting considerable genetic regulation at fatty acids levels. We find low genetic correlations between traditional lipids and lipid species. Our results show that lipidomic profiles capture information beyond traditional lipids and identify genetic variants modifying lipid levels and risk of CVD.
Cardiovascular diseases (CVD) are associated with plasma lipid levels. Here, Tabassum et al. perform genome-wide association studies for lipidomic profiles with 141 (non-standard) lipid species which highlights shared genetic loci with CVD and that traditional lipids have low genetic correlation with other lipids.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
2 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Broad Institute of MIT and Harvard, Program in Medical and Population Genetics and Genetic Analysis Platform, Stanley Center for Psychiatric Research, Cambridge, USA (GRID:grid.66859.34); Massachusetts General Hospital, Psychiatric & Neurodevelopmental Genetics Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
3 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, USA (GRID:grid.66859.34); Massachusetts General Hospital and Harvard Medical School, Analytic and Translational Genetics Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
4 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Tartu, Estonian Genome Center, Institute of Genomics, Tartu, Estonia (GRID:grid.10939.32) (ISNI:0000 0001 0943 7661)
5 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); National Institute for Health and Welfare, Helsinki, Finland (GRID:grid.14758.3f) (ISNI:0000 0001 1013 0499)
6 Helsinki University Hospital, Research Programs Unit, Diabetes & Obesity, University of Helsinki and Department of Internal Medicine, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666)
7 Helsinki University Hospital, Research Programs Unit, Diabetes & Obesity, University of Helsinki and Department of Internal Medicine, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666); Helsinki University Hospital, Endocrinology, Abdominal Center, Helsinki, Finland (GRID:grid.15485.3d) (ISNI:0000 0000 9950 5666)
8 Lipotype GmbH, Dresden, Germany (GRID:grid.15485.3d)
9 Lipotype GmbH, Dresden, Germany (GRID:grid.15485.3d); Łukasiewicz Research Network-PORT Polish Center for Technology Development, Wroclaw, Poland (GRID:grid.15485.3d)
10 Washington University School of Medicine, Cardiovascular Division, Department of Medicine, Saint Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Washington University School of Medicine, Department of Genetics, Saint Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Washington University School of Medicine, McDonnell Genome Institute, Saint Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
11 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Faculty of Medicine and Health Technology, Department of Obstetrics and Gynecology, Tampere University Hospital and Tampere University, Tampere, Finland (GRID:grid.7737.4); University of Helsinki and Helsinki University Hospital, Medical and Clinical Genetics, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
12 University of California, Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
13 National Institute for Health and Welfare, Helsinki, Finland (GRID:grid.14758.3f) (ISNI:0000 0001 1013 0499)
14 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Helsinki, Department of Public Health, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Helsinki, Helsinki Institute for Information Technology HIIT and Department of Mathematics and Statistics, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
15 Abbvie, Chicago, USA (GRID:grid.431072.3) (ISNI:0000 0004 0572 4227)
16 Astra Zeneca, Cambridge, UK (GRID:grid.431072.3)
17 Auria Biobank, University of Turku and Hospital District of Southwest Finland, Turku, Finland (GRID:grid.426612.5) (ISNI:0000 0004 0366 9623)
18 Auria Biobank, Turku, Finland (GRID:grid.426612.5)
19 University of Eastern Finland and Northern Savo Hospital District, Biobank of Eastern Finland, Kuopio, Finland (GRID:grid.9668.1) (ISNI:0000 0001 0726 2490)
20 Biobank of Eastern Finland, Kuopio, Finland (GRID:grid.9668.1)
21 Biogen, Cambridge, USA (GRID:grid.417832.b) (ISNI:0000 0004 0384 8146)
22 Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, USA (GRID:grid.66859.34)
23 Business Finland, Helsinki, Finland (GRID:grid.66859.34)
24 Celgene, Summit, USA (GRID:grid.418722.a) (ISNI:0000 0004 0461 1802)
25 University of Jyväskylä and Central Finland Health Care District, Central Finland Biobank, Jyväskylä, Finland (GRID:grid.460356.2) (ISNI:0000 0004 0449 0385)
26 Central Finland Biobank, Jyväskylä, Finland (GRID:grid.460356.2)
27 Central Finland Health Care District, Jyväskylä, Finland (GRID:grid.460356.2) (ISNI:0000 0004 0449 0385)
28 University of Tampere and Pirkanmaa Hospital District, Finnish Clinical Biobank Tampere, Tampere, Finland (GRID:grid.502801.e) (ISNI:0000 0001 2314 6254)
29 Finnish Red Cross Blood Service and Finnish Hematology Registry and Clinical Biobank, Helsinki, Finland (GRID:grid.452433.7) (ISNI:0000 0000 9387 9501)
30 Genentech, San Francisco, USA (GRID:grid.418158.1) (ISNI:0000 0004 0534 4718)
31 GlaxoSmithKline, Brentford, UK (GRID:grid.418236.a) (ISNI:0000 0001 2162 0389)
32 Helsinki Biobank, Helsinki, Finland (GRID:grid.418236.a)
33 HiLIFE, University of Helsinki, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
34 Hospital District of Helsinki and Uusimaa, Helsinki, Finland (GRID:grid.424664.6) (ISNI:0000 0004 0410 2290)
35 Hospital District of Southwest Finland, Turku, Finland (GRID:grid.426612.5) (ISNI:0000 0004 0366 9623)
36 Merck, Kenilworth, USA (GRID:grid.417993.1) (ISNI:0000 0001 2260 0793)
37 University of Oulu and Northern Ostrobothnia Hospital District, Northern Finland Biobank Borealis, Oulu, Finland (GRID:grid.437577.5)
38 Northern Ostrobothnia Hospital District, Oulu, Finland (GRID:grid.437577.5)
39 Northern Savo Hospital District, Kuopio, Finland (GRID:grid.437577.5)
40 Pfizer, New York, USA (GRID:grid.410513.2) (ISNI:0000 0000 8800 7493)
41 Pirkanmaa Hospital District, Tampere, Finland (GRID:grid.415018.9) (ISNI:0000 0004 0472 1956)
42 Sanofi, Paris, France (GRID:grid.417924.d)
43 University of Helsinki, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)
44 University of Stanford, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956)
45 University of Tampere, Tampere, Finland (GRID:grid.502801.e) (ISNI:0000 0001 2314 6254)
46 National Institute for Health and Welfare, Helsinki, Finland (GRID:grid.14758.3f) (ISNI:0000 0001 1013 0499); Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Finland (GRID:grid.452540.2)
47 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, USA (GRID:grid.66859.34)
48 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, USA (GRID:grid.66859.34); Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, Analytic and Translational Genetics Unit, Department of Medicine, and the Department of Neurology, Massachusetts General Hospital, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
49 Lipotype GmbH, Dresden, Germany (GRID:grid.15485.3d); Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany (GRID:grid.419537.d) (ISNI:0000 0001 2113 4567)
50 HiLIFE, University of Helsinki, Institute for Molecular Medicine Finland, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Broad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, USA (GRID:grid.66859.34); University of Helsinki, Department of Public Health, Clinicum, Faculty of Medicine, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071)